1. Market Research
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight
6 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Chronic Lower Back Pain (CLBP) - Market Insight, Epidemiology and Market Forecast -2030

  • $ 6950
  • April 2020
  • 200 pages

Non-opioids Analgesics ##. ##. ##.

  • Chronic Disease
  • Chronic Pain
  • Salicylic Acid
  • Therapy
  • United States

Lamellar Ichthyosis (LI)-Market Insights, Epidemiology and Market Forecast-2030

  • $ 6950
  • March 2020
  • 200 pages

However, some keratolytics such as salicylic acid can be absorbed through the skin with potentially harmful side effects on the body.

  • Dermatological Condition
  • Pathology
  • Salicylic Acid
  • Therapy
  • United States

Duchenne Muscular Dystrophy- Market Insight, Epidemiology and Market Forecast -2030

  • $ 6950
  • April 2020
  • 150 pages

Edasalonexent is a conjugate of salicylic acid and docosahexaenoic acid (DHA) that targets to inhibit activated NF-?

  • Mental Health
  • Neurological Disorder
  • Salicylic Acid
  • Therapy
  • United States

Essential Thrombocythemia (ET)-Market Insights, Epidemiology, and Market Forecast–2030

  • $ 6950
  • May 2020
  • 200 pages

Both aspirin and IFN-?

  • Blood Disease
  • Pathology
  • Salicylic Acid
  • Therapy
  • United States

Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2030

  • $ 6950
  • June 2020
  • 200 pages

Various other supportive therapies antihistamines, allopurinol, aspirin are also recommended.

  • Blood Disease
  • Pathology
  • Salicylic Acid
  • Therapy
  • Spain

Dilated Cardiomyopathy (DCM) - Market Insights, Epidemiology and Market Forecast —2030

  • $ 6950
  • May 2020
  • 200 pages

Less strong anticoagulation medications include aspirin and dipyridamole.

  • Cardiovascular Disease
  • Chronic Disease
  • Salicylic Acid
  • Therapy
  • United States


View report >

Hospital Social Impact in Texas (USA)

  • January 2019
  • 70 pages

OF ##, ## MI CASES SEEN BETWEEN 2008 AND 2018, ##. ##% WERE PRESCRIBED ASPIRIN WITHIN THE FIRST ## HOURS OF EITHER FIRST MEDICAL CONTACT OR HOSPITAL ARRIVAL, ##. ##% WERE NOT PRESCRIBED ASPIRIN, AND ##. ##% HAD CONTRAINDICATIONS TO ASPIRIN USE (PG. ##).

  • Health Services
  • Heart Attack
  • Hospital
  • Salicylic Acid
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on